Washington, DC · hospital rates, itemized

Blood clotting test (PT/INR) at Howard University Hospital Corp

2041 Georgia Avenue NW, Washington, DC 20060. From the hospital's federally required price file (v3.0.0), file date December 31, 2025source file. Last verified by PriceCheck: July 16, 2026. CPT 85610.

$52
Cash price
$28
Median commercial
$65
Gross charge (list)

Median commercial rate here: $28 — 28% above the Washington, DC metro median of $22. Compare all Washington, DC hospitals →

Commercial insurance plans

Payer / planFacility rateRate type
United HealthcareAll Payer $4 negotiated rate
AetnaHMO & PPO $14 negotiated rate
CignaAll Other (+1 same-rate plans) $41 negotiated rate
CarefirstPPO $165 negotiated rate
What these numbers are — and aren't. These are facility rates hospitals publish under the CMS Hospital Price Transparency rule (45 CFR Part 180). They are price information, not a quote or guarantee. Physician, anesthesia, radiology, and pathology services usually bill separately. Your actual cost depends on your insurance plan, deductible, and how the visit is coded. How we read hospital price files →

Common questions

How much does blood clotting test (pt/inr) cost at Howard University Hospital Corp without insurance?

Howard University Hospital Corp's price file lists a discounted cash (self-pay) facility rate of $52 for Blood clotting test (PT/INR), against a gross charge of $65. Facility rate only — physician, anesthesia, radiology, and pathology services bill separately.

What do insurance plans pay for blood clotting test (pt/inr) at Howard University Hospital Corp?

Howard University Hospital Corp lists 4 commercial plan rates for Blood clotting test (PT/INR), from $4 (United Healthcare) to $165 (Carefirst), with a median of $28. The Washington, DC metro median commercial rate for this procedure is $22.

Where do these prices come from?

Directly from the machine-readable file Howard University Hospital Corp publishes under the CMS Hospital Price Transparency rule (45 CFR Part 180), file date December 31, 2025. These are price disclosures, not quotes.